GBI 0.00% 16.0¢ genera biosystems limited

Ann: Appendix 4D Half Yearly Report and Accounts , page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 371 Posts.
    re: Ann: Appendix 4D Half Yearly Report and A... Liq I agree with a marke cap of $12m its unreailistic for someone to pay $50-$75m.

    That's not to say GBI's market cap is going to be where it is now before a bid comes on a firm basis.

    Data next month (if it is the same as last October's will help spike it up) also a succesful TGA audit also next month shoudl mean manufacturing is ready to go. These 2 factors then bode well for CE Mark in June.

    Looking for a partnering deal to be announced with 4-6 weeks after the April data is released as well.

    These all hopefully should push the market cap up nicely so that a $50 to $75m offer isn't away with the fairies.

    Yes Thirdwave got sold before the recent turmoil market capitulation but the offer of US$345m in August 2008 was well after the market started to turn in late 2007/early 2008.

    Let's hope the planets align here

    cheers

    PS...SRX was a great example of a market cap 6-9 months prior to a sale bearing little relevance to an offer price.

    Check out the SRX chart back in 2002/03. Nice move up between June 2002 and January 2003 when Cephalon announced its bid at $4.85 cash
 
watchlist Created with Sketch. Add GBI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.